2018
Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors
O'Connor JM, Seidl‐Rathkopf K, Torres AZ, You P, Carson KR, Ross JS, Gross CP. Disparities in the Use of Programmed Death 1 Immune Checkpoint Inhibitors. The Oncologist 2018, 23: 1388-1390. PMID: 30012876, PMCID: PMC6291337, DOI: 10.1634/theoncologist.2017-0673.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerAnti-PD1 agentsAnti-PD1 treatmentImmune checkpoint inhibitorsCheckpoint inhibitorsDeath-1 immune checkpoint inhibitorPrior anticancer therapyDeath protein 1Cell lung cancerCommunity-based cohortAdvanced-stage cancerRenal cell carcinomaSex-based disparitiesSystemic treatmentCell carcinomaLung cancerMultivariable modelObservational studyHigher oddsStage cancerRace-based disparitiesPatient careAnticancer therapyProtein 1Patients
2013
Age-based and Sex-based Disparities in Screening Colonoscopy Use Among Medicare Beneficiaries
Gancayco J, Soulos PR, Khiani V, Cramer LD, Ross JS, Genao I, Tinetti M, Gross CP. Age-based and Sex-based Disparities in Screening Colonoscopy Use Among Medicare Beneficiaries. Journal Of Clinical Gastroenterology 2013, 47: 630-636. PMID: 23619827, DOI: 10.1097/mcg.0b013e31828345c8.Peer-Reviewed Original ResearchConceptsColonoscopy useScreening colonoscopyColonoscopy ratesLife expectancyMedicare beneficiariesOlder personsColorectal cancer incidencePatient demographic characteristicsLow screening ratesSex-based disparitiesShort life expectancySex-based differencesLonger life expectancyPatients 68Older patientsPatients 75Screening ratesCancer incidenceLarge cohortMedicare claimsColonoscopyMedicare dataPatientsPoisson regressionLife table approach